Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. FTNT
4. QCOM
5. ARM
6. SBUX
7. TENB
8. CVNA
9. CMG
10. EQIX

Go back to Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
(NASDAQ: APLM) Delayed: 17.35 -0.13 (0.74%)
Previous Close $17.48    52 Week High $ 
Open $17.20    52 Week Low $ 
Day High $17.80    P/E N/A 
Day Low $17.10    EPS $ 
Volume 3,563